株式会社ファンペップTSE 4881

株式会社ファンペップ · Pharmaceutical · FY ends Dec

Share price at FY-end
—
FY ending Dec 2025
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥11.6M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Shionogi Pharmaceutical Co., Ltd. 2,682,500 6.61% — —
2 楽天証券株式会社 1,428,900 3.52% — —
3 SBI4&5投資事業有限責任組合 1,190,400 2.93% — —
4 三好 稔美 1,125,000 2.77% — —
5 株式会社SBI証券 903,998 2.23% — —
6 株式会社ReBeage 800,000 1.97% — —
7 New Life Science1号投資事業有限責任組合 793,600 1.96% — —
8 有限会社アドバンステクノロジー 700,000 1.73% — —
9 吉田 克己 648,600 1.60% — —
10 Medipal Holdings Co., Ltd. 595,200 1.47% — —

Officers' holdings and pay

NameTitleSharesValuePay
三好 稔美 President & Representative Director 1,125,000 — —
冨岡 英樹 Director 105,000 — —
林 毅俊 Director, CFO — — —
栄木 憲和 Director 50,000 — —
原 誠 Director — — —
堀口 基次 Full-time Audit & Supervisory Board Member — — —
眞鍋 淳也 Audit & Supervisory Board Member — — —
樋口 尚文 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 — ¥-50.20 — — 40,563,800
FY ending Dec 2024 — ¥-31.98 — — 32,408,800
FY ending Dec 2023 — ¥-39.63 — — 24,236,500
FY ending Dec 2022 — ¥-61.04 — — 21,399,900
FY ending Dec 2021 — ¥-39.58 — — 17,786,100
Source: annual securities reports on EDINET. Values are estimates. Methodology